Leukemia & Lymphoma
Latest Publications

TOTAL DOCUMENTS

12626

(FIVE YEARS 1841)

H-INDEX

81

(FIVE YEARS 11)

Published By Informa Uk (Taylor & Francis)

1029-2403, 1042-8194

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Rapid liver atrophy and refractory ascites due to hepatoportal sclerosis in a patient after haploidentical stem cell transplantation

Leukemia & Lymphoma ◽

10.1080/10428194.2022.2027400 ◽

2022 ◽

pp. 1-4

Author(s):

Daisuke Ikeda ◽

Takafumi Tsushima ◽

Ami Fukumoto ◽

Ayumi Kuzume ◽

Rikako Tabata ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Refractory Ascites ◽

Liver Atrophy ◽

Hepatoportal Sclerosis ◽

Haploidentical Stem Cell Transplantation

Download Full-text

CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Leukemia & Lymphoma ◽

10.1080/10428194.2021.2023741 ◽

2022 ◽

pp. 1-5

Author(s):

Trine Engelbrecht Hybel ◽

Maja Ølholm Vase ◽

Kristina Lystlund Lauridsen ◽

Marie Beck Enemark ◽

Michael Boe Møller ◽

...

Keyword(s):

Human Immunodeficiency Virus ◽

Potential Treatment ◽

Treatment Target ◽

Immunodeficiency Virus

Download Full-text

Coming of age: the evolving role of circulating tumor DNA in malignant lymphoma

Leukemia & Lymphoma ◽

10.1080/10428194.2022.2027404 ◽

2022 ◽

pp. 1-3

Author(s):

Jan-Michel Heger ◽

Sven Borchmann

Keyword(s):

Malignant Lymphoma ◽

Coming Of Age ◽

Circulating Tumor Dna ◽

Download Full-text

Specific TCR V–J gene segment recombinations leading to the identification pan-V–J CDR3s associated with survival distinctions: diffuse large B-cell lymphoma

Leukemia & Lymphoma ◽

10.1080/10428194.2021.2020781 ◽

2022 ◽

pp. 1-9

Author(s):

Konrad J. Cios ◽

Taha I. Huda ◽

Rachel A. Eakins ◽

Moody M. Mihyu ◽

George Blanck

Keyword(s):

B Cell ◽

Cell Lymphoma ◽

Gene Segment ◽

B Cell Lymphoma ◽

Large B Cell Lymphoma ◽

Download Full-text

Up to 6.5 years (median 4 years) of follow-up of first-line ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma and high-risk genomic features: integrated analysis of two phase 3 studies

Leukemia & Lymphoma ◽

10.1080/10428194.2021.2020779 ◽

2022 ◽

pp. 1-12

Author(s):

Jan A. Burger ◽

Tadeusz Robak ◽

Fatih Demirkan ◽

Osnat Bairey ◽

Carol Moreno ◽

...

Keyword(s):

High Risk ◽

Chronic Lymphocytic Leukemia ◽

Lymphocytic Leukemia ◽

Integrated Analysis ◽

Small Lymphocytic Lymphoma ◽

Phase 3 ◽

Two Phase ◽

Genomic Features

Download Full-text

Lymphocyte HLA-DR/CD-38 co-expression correlates with Hodgkin lymphoma cell cytotoxicity in vitro independent of PD-1/PD1-L pathway

Leukemia & Lymphoma ◽

10.1080/10428194.2021.2023744 ◽

2022 ◽

pp. 1-8

Author(s):

Meret Henry ◽

Steven Buck ◽

Batool Al-Qanber ◽

Manisha Gadgeel ◽

Süreyya Savasan

Keyword(s):

Hodgkin Lymphoma ◽

Lymphoma Cell ◽

Cell Cytotoxicity ◽

Hla Dr ◽

Hodgkin Lymphoma Cell

Download Full-text

Evaluation of central line salvage for mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) management practices in patients with hematologic malignancies

Leukemia & Lymphoma ◽

10.1080/10428194.2021.2020778 ◽

2022 ◽

pp. 1-9

Author(s):

Zeinab El Boghdadly ◽

Qiuhong Zhao ◽

Jean Koutou ◽

Mark E. Lustberg ◽

Madeline Ludwig ◽

...

Keyword(s):

Bloodstream Infection ◽

Management Practices ◽

Hematologic Malignancies ◽

Central Line ◽

Mucosal Barrier ◽

Mucosal Barrier Injury

Download Full-text

The treatment landscape for Relapsed Refractory B Acute Lymphoblastic Leukaemia (ALL)

Leukemia & Lymphoma ◽

10.1080/10428194.2021.2020780 ◽

2022 ◽

pp. 1-10

Author(s):

Kirsty Marie Sharplin ◽

David Marks

Keyword(s):

Acute Lymphoblastic Leukaemia ◽

Lymphoblastic Leukaemia

Download Full-text

Second primary malignancy risk after Hodgkin lymphoma treatment among HIV-uninfected and HIV-infected survivors

Leukemia & Lymphoma ◽

10.1080/10428194.2021.2020775 ◽

2022 ◽

pp. 1-11

Author(s):

Renata Abrahão ◽

Ann M. Brunson ◽

Justine M. Kahn ◽

Qian W. Li ◽

Ted Wun ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Second Primary ◽

Second Primary Malignancy ◽

Primary Malignancy ◽

Malignancy Risk ◽

Lymphoma Treatment

Download Full-text

Improving outcomes in limited-stage de novo CD5+ DLBCL: systemic approaches with consolidative radiation

Leukemia & Lymphoma ◽

10.1080/10428194.2021.2023742 ◽

2022 ◽

pp. 1-6

Author(s):

Jurui Ge ◽

Yaqin Xia ◽

Zhenchang Sun ◽

Lei Zhang ◽

Xin Li ◽

...

Keyword(s):

De Novo ◽

Download Full-text